Dana-Farber to retract six papers, correct 31, over “image discrepancies” in papers co-authored by top leaders January 26, 2024Vol.50 No.04By Jacquelyn Cobb
Real-world Evidence Flatiron, Caris combine EHR, multi-omics data to support precision oncology January 26, 2024Vol.50 No.04By Matthew Bin Han Ong
Guest Editorial The growing need for cancer patient navigation and how to meet it January 26, 2024Vol.50 No.04By Alyssa Schatz and Crystal S. Denlinger
Guest Editorial Reflecting on Janet Woodcock’s retirement from FDA January 26, 2024Vol.50 No.04By Ellen V. Sigal
In Brief Shikhar Mehrotra named co-leader of Cancer Biology and Immunology research program at MUSC Hollings January 26, 2024Vol.50 No.04
In Brief Alexandra Miller named chief of neuro-oncology and co-director of Brain and Spine Tumor Center at NYU Perlmutter January 26, 2024Vol.50 No.04
In Brief LSU LCMC Health research team granted $1.2M to address barriers to cervical cancer prevention January 26, 2024Vol.50 No.04
In Brief UMass’s Stacyann Bailey receives $400,000 from NCI to research whether checkpoint inhibitors worsen bone damage in metastatic cancer January 26, 2024Vol.50 No.04
Clinical Roundup Long-term follow-up pinpoints side effects of prostate cancer treatments January 26, 2024Vol.50 No.04
Clinical Roundup Study determines factors affecting decisions regarding active surveillance in low-risk prostate cancer January 26, 2024Vol.50 No.04
